SCHEMBL7195094

SCHEMBL7195094

CCc1cc(NC(=O)c2ccc(C)cc2N2CCC(C)CC2)ccc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.50
TDP1 Q9NUW8 3/20 0.50
LMNA P02545 2/20 0.50
GAA P10253 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.43
TP53 P04637 3/20 0.43
ALDH1A1 P00352 7/20 0.43
KDM4E B2RXH2 4/20 0.43
MAPK1 P28482 2/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
GLA P06280 1/20 0.42
MCL1 Q07820 1/20 0.42
POLB P06746 3/20 0.41
NR4A1 P22736 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7199389 0.88 MAPT (0.50) MAPTTDP1LMNAGAAL3MBTL1
SCHEMBL6647782 0.85 THRB (0.53) MAPTTDP1LMNAGAAL3MBTL1
SCHEMBL6643264 0.80 MAPT (0.50) MAPTTDP1LMNAGAASMN1; SMN2
SCHEMBL6643012 0.80 HTT (0.54) MAPTTDP1LMNAGAASMN1; SMN2
SCHEMBL6831102 0.77 MAPT (0.45) MAPTTDP1LMNAGAAL3MBTL1
SCHEMBL16448843 0.75 L3MBTL1 (0.51) MAPTTDP1LMNAGAAL3MBTL1
SCHEMBL6648726 0.75 ADRB2 (0.43) MAPTTDP1LMNAGAASMN1; SMN2
SCHEMBL6643855 0.74 ALDH1A1 (0.48) MAPTGAAL3MBTL1SMN1; SMN2TP53
SCHEMBL16448842 0.73 HTT (0.65) MAPTTDP1LMNAGAAL3MBTL1
SCHEMBL6646925 0.73 GFER (0.40) MAPTTDP1LMNAL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed